Systematic review and network meta‐analysis of re‐intervention rates of new surgical interventions for benign prostatic hyperplasia
Authors:
Open Access
- 10 April 2024
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 134 (2) , 155-165
Abstract
Objective: To assess the re‐intervention rates of new surgical benign prostatic hyperplasia (BPH) interventions, as the clinical durability of new surgical interventions for BPH is not widely known. Methods: A critical review of new surgical BPH therapies namely ‘UroLift®’, ‘Aquablation’, ‘Rezum’, ‘prostatic artery embolisation (PAE)’ and ‘temporary implantable nitinol device (iTIND)’ was performed on PubMed, the Cochrane Library, and Embase databases between May 2010 and December 2022 according to the Preferred Reporting Items for Systematic Review and Meta‐analyses (PRISMA) statement. All relevant articles were reviewed, and the risk of bias was evaluated using the Cochrane risk assessment tool and Newcastle–Ottawa Scale. Results: Of the 32 studies included, there were 10 randomised controlled trials and 22 prospective observational cohorts. A total of 2400 participants were studied with a median patient age of 66 years, a median prostate volume of 51.9 mL, and a median International Prostate Symptom Score of 22. The lowest re‐intervention rate at 12 months was for Aquablation at 0.01%, followed by Rezum at 0.02%, iTIND at 0.03%, and PAE at 0.05%. Network meta‐analysis (NMA) showed that the best‐ranked treatment at 12 months was transurethral resection of the prostate (TURP), followed by Aquablation, iTIND, Rezum, and UroLift. Re‐intervention rates with these new BPH interventions are comparable, although some interventions reported better outcomes than TURP in the shorter term. Conclusions: While this systematic review and NMA showed that the re‐intervention rate with these new surgical BPH interventions appears to be comparable to TURP in the short term, further studies are required to directly compare these various BPH procedures.Keywords
This publication has 40 references indexed in Scilit:
- A Systematic Review of Patients’ Values, Preferences, and Expectations for the Diagnosis and Treatment of Male Lower Urinary Tract SymptomsEuropean Urology, 2021
- Water vapor therapy (Rezūm) for lower urinary tract symptoms related to benign prostatic hyperplasia: early results from the first Italian multicentric studyWorld Journal of Urology, 2021
- A Systematic Review and Meta-analysis of Prostatic Urethral Lift for Male Lower Urinary Tract Symptoms Secondary to Benign Prostatic HyperplasiaEuropean Urology Open Science, 2020
- Efficacy and safety of aquablation of the prostate for patients with symptomatic benign prostatic enlargement: a systematic reviewWorld Journal of Urology, 2019
- Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 yearsWorld Journal of Urology, 2018
- Prostate Artery Embolization for Complete Urinary Outflow Obstruction Due to Benign Prostatic HypertrophyCardioVascular and Interventional Radiology, 2016
- Transurethral Resection of the Prostate (TURP) Versus Original and PErFecTED Prostate Artery Embolization (PAE) Due to Benign Prostatic Hyperplasia (BPH): Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled AnalysisCardioVascular and Interventional Radiology, 2015
- Prospective, Randomized, Multinational Study of Prostatic Urethral Lift Versus Transurethral Resection of the Prostate: 12-month Results from the BPH6 StudyEuropean Urology, 2015
- Drug Adherence and Clinical Outcomes for Patients Under Pharmacological Therapy for Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Population-based Cohort StudyEuropean Urology, 2015
- Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-upEuropean Radiology, 2013